Interferon-induced depression: Mechanisms and management

British Journal of Hospital Medicine

Volumn 68, Issue 6, 2007, Pages 307-310

  Hafizi, Sepehr ^a   Favaron, Elisa ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOOXYGENASE 2; DULOXETINE; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; KYNURENINE; MIRTAZAPINE; NORADRENALIN; PAROXETINE; PROTEINASE INHIBITOR; RIBAVIRIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

AMINO ACID METABOLISM; ANOREXIA; BLOOD BRAIN BARRIER; CHRONIC MYELOID LEUKEMIA; DELIRIUM; DEPRESSION; DRUG EFFECT; DRUG MEGADOSE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; KIDNEY CARCINOMA; LETHARGY; MAJOR DEPRESSION; MANIA; MELANOMA; MULTIPLE SCLEROSIS; PSYCHOMOTOR RETARDATION; REVIEW;

EID: 34250812006     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2007.68.6.23570     Document Type: Review

References (20)

1. Angelino AF, Treisman GJ (2005) Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients. Int Rev Psychiatry 17: 471-6
2. Asnis GM, De La Garza R, 2nd (2005) Interferon-induced depression: strategies in treatment. Prog Neuropsychopharmacol Biol Psychiatry 29: 808-18
3. Bonaccorso S, Puzella A, Marino V et al (2001) Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 105: 45-55
4. Bonaccorso S, Marino V, Puzella A et al (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22: 86-90
5. Cai W, Khaoustov VI, Xie Q, Pan T, Le W, Yoffe B (2005) Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J Hepatol 42: 880-7
6. Capuron L, Dantzer R (2003) Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17(Suppl 1): S119-124
7. Capuron L, Miller AH (2004) Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56: 819-24
8. Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ (2002) Treatment of cytokine-induced depression. Brain Behav Immun 16: 575-80
9. Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH (2003) Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 160: 1342-5
10. Collantes-Estevez E, Fernandez-Perez C (2003) Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. Curr Med Res Opin 19: 402-10
11. Frick B, Capuron L, Schrocksnadel K et al (2004) Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. J Interferon Cytokine Res 24: 311-17
12. Linthorst AC, Flachskamm C, Muller-Preuss P, Holsboer F, Reul JM (1995) Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J Neurosci 15: 2920-34
13. Mann JJ (2005) The medical management of depression. N Engl J Med 353: 1819-34
14. Meyers CA, Scheibel RS, Forman AD (1991) Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41: 672-6
15. Musselman DL, Lawson DH, Gumnick JF et al (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344: 961-6
16. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24-31
17. Saito K, Crowley JS, Markey SP, Heyes MP (1993) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem 268: 15496-503
18. Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 201-17
19. Takikawa O (2005) Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun 338: 12-19
20. Turner EH, Blackwell AD (2005) 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Med Hypotheses 65: 138-44